Steve K. Barbarick - Sep 9, 2021 Form 4 Insider Report for Statera Biopharma, Inc. (STAB)

Role
Director
Signature
/s/ Peter Aronstam, Attorney-in-fact for Steve K. Barbarick
Stock symbol
STAB
Transactions as of
Sep 9, 2021
Transactions value $
$0
Form type
4
Date filed
10/19/2021, 04:05 PM
Previous filing
Jul 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAB Common Stock, par value $0.005 per share Award $0 +60K $0.00 60K Sep 9, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs) that were granted pursuant to the Cleveland Biolabs, Inc. Equity Incentive Plan. The RSUs will be settled solely with Issuer Common Stock and vest in equal monthly portions over the period of 36 months from the grant date, provided that the Reporting Person continues to provide services to the Issuer through each vesting date.